semaglutide smell sensitivity burping: why it happens and how to stop it Do GLP-1s Like Ozempic, Mounjaro

Future randomised controlled trials should specifically evaluate the effectiveness of novel AOMs for long-term weight management in older adults with obesity, carefully considering the impact on body composition and functional ability, as well as health economics.

This local paracrine GLP-1 signalling seems to be specifically involved in the perception of sweets

This analysis in #JCOOP showed a nearly 30% drop in incidencefrom 2.3% to 1.6% and it has generated a lot of discussion

Should GLP-1 therapy extend to normal-weight patients with cardiometabolic risk

A high dose of Novo Nordisks obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than whats been seen with Zepbound.